+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cellular Immunotherapy Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5345446
  • Report
  • June 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd
Cellular Immunotherapy Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global cellular immunotherapy market.







This report focuses on cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the cellular immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the cellular immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cellular Immunotherapy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cellular immunotherapy market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cellular immunotherapy market section of the report gives context. It compares the cellular immunotherapy market with other segments of the cellular immunotherapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cellular immunotherapy indicators comparison.

Scope

Markets Covered:

1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Others
3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumour; Lung Cancer; Others

Companies Mentioned: Novartis AG; Gilead Sciences Inc. (Kite Pharma); Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Cellular Immunotherapy Market

What is the estimated value of the Global Cellular Immunotherapy Market?

The Global Cellular Immunotherapy Market was estimated to be valued at $3.6 billion in 2021.

What is the growth rate of the Global Cellular Immunotherapy Market?

The growth rate of the Global Cellular Immunotherapy Market is 17.0%, with an estimated value of $6.7 billion by 2025.

What is the forecasted size of the Global Cellular Immunotherapy Market?

The Global Cellular Immunotherapy Market is estimated to be worth $6.7 billion by 2025.

Who are the key companies in the Global Cellular Immunotherapy Market?

Key companies in the Global Cellular Immunotherapy Market include Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol and Pfizer Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd

1. Executive Summary2. Cellular Immunotherapy Market Characteristics3. Cellular Immunotherapy Market Trends And Strategies4. Impact Of COVID-19 On Cellular Immunotherapy
5. Cellular Immunotherapy Market Size And Growth
5.1. Global Cellular Immunotherapy Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cellular Immunotherapy Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Cellular Immunotherapy Market Segmentation
6.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Tumour-Infiltrating Lymphocyte (TIL) Therapy
  • Engineered T Cell Receptor (TCR) Therapy
  • Chimeric Antigen Receptor (CAR)
  • T Cell Therapy
  • Natural Killer (NK) Cell Therapy
6.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • B-cell Malignancies
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Liver Cancer
  • Non-Hodgkin lymphoma
  • Others 3
6.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Ovarian Cancer
  • Brain Tumour
  • Lung Cancer
  • Others

7. Cellular Immunotherapy Market Regional And Country Analysis
7.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Cellular Immunotherapy Market
8.1. Asia-Pacific Cellular Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Cellular Immunotherapy Market
9.1. China Cellular Immunotherapy Market Overview
9.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Cellular Immunotherapy Market
10.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Cellular Immunotherapy Market
11.1. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Cellular Immunotherapy Market
12.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Cellular Immunotherapy Market
13.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Cellular Immunotherapy Market
14.1. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Cellular Immunotherapy Market
15.1. Western Europe Cellular Immunotherapy Market Overview
15.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Cellular Immunotherapy Market
16.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Cellular Immunotherapy Market
17.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Cellular Immunotherapy Market
18.4. France Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Cellular Immunotherapy Market
19.1. Eastern Europe Cellular Immunotherapy Market Overview
19.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Cellular Immunotherapy Market
20.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Cellular Immunotherapy Market
21.1. North America Cellular Immunotherapy Market Overview
21.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Cellular Immunotherapy Market
22.1. USA Cellular Immunotherapy Market Overview
22.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Cellular Immunotherapy Market
23.1. South America Cellular Immunotherapy Market Overview
23.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Cellular Immunotherapy Market
24.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Cellular Immunotherapy Market
25.1. Middle East Cellular Immunotherapy Market Overview
25.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Cellular Immunotherapy Market
26.1. Africa Cellular Immunotherapy Market Overview
26.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Cellular Immunotherapy Market Competitive Landscape And Company Profiles
27.1. Cellular Immunotherapy Market Competitive Landscape
27.2. Cellular Immunotherapy Market Company Profiles
27.2.1. Novartis AG
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Gilead Sciences Inc. (Kite Pharma)
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Apac Biotech
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Dendreon Pharmaceuticals LLC
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. JW CreaGene Co. Ltd
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Cellular Immunotherapy Pipeline Analysis29. Key Mergers And Acquisitions In The Cellular Immunotherapy Market30. Cellular Immunotherapy Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adicet Bio
  • Apac Biotech
  • AstraZeneca
  • Bristol-Myers Squibb
  • Celyad
  • JW CreaGene Co. Ltd
Major players in the cellular immunotherapy market are Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc., and Roche.

The global cellular immunotherapy market is expected to grow from $2.74 billion in 2020 to $3.59 billion in 2021 at a compound annual growth rate (CAGR) of 31%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.73 billion in 2025 at a CAGR of 17%.

The cellular immunotherapy market consists of revenues generated by the companies engaged in developing, manufacturing, and sales of cellular immunotherapy drugs. Cellular immunotherapy is also known as adoptive cell therapy, a form of treatment that utilizes the cells of the immune system to eliminate diseases including non-Hodgkin lymphoma, cancer, and acute lymphoblastic leukaemia.

The cellular immunotherapy market covered in this report is segmented by therapy into tumor-infiltrating lymphocyte (TIL) therapy; engineered T cell receptor (TCR) therapy; chimeric antigen receptor (CAR) T cell therapy; natural killer (NK) cell therapy. It is also segmented by primary indication into b-cell malignancies; prostate cancer; renal cell carcinoma; liver cancer; non-Hodgkin lymphoma; others and by application into prostate cancer; breast cancer; skin cancer; ovarian cancer; brain tumour; lung cancer; others.

The high cost of cellular immunotherapies is anticipated to hinder the cellular immunotherapy’s market growth. CAR-T therapy is a type of cellular immunotherapy and only two have been approved in the USA. The price of Yescarta and Kymriah is more than $350,000 per treatment in the USA, which is highly unaffordable for a majority of the patients especially with low income. The high cost of cellular immunotherapies discourages patients to opt for this drug, thereby, impacting the demand and the market negatively.

Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient cells as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast, and quality control production. For instance, in November 2019, Precision Biosciences, Inc., a biotechnology company, has created a new generation allogeneic CAR-T therapy and is conducting an ongoing trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is in collaboration with Servier, an international pharmaceutical company, and is mainly for the patients in need of advanced cancer treatment options. Additionally, in August 2020, Acepodia, a US-based next-generation cell immuno-technology company, initiated a phase 1 clinical trial for evaluating ACE1702 an allogeneic, off-the-shelf NK cell therapy for the treatment of solid tumors.

In April 2020, resTORbio, Inc., a US-based biopharmaceutical company specialized in the development and commercialization of drugs used for the treatment of aging-related diseases, merged with Adicet Bio, Inc., a biopharmaceutical company, for an undisclosed amount. Both the companies continue their operations as ‘Adicet Bio’. This merger is expected to help the companies in advancing allogeneic gamma-delta CAR-T cell therapy technology. Adicet Bio, Inc. is a US-based company specialized in the development of Adicet’s off-the-shelf allogeneic gamma delta T cell therapies for oncology and other indications.

Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases. The rapid growth in the development of cellular immunotherapy in clinical and preclinical stages in 2020 as compared to that in 2019 is projected to expand the landscape of cellular immunotherapy. Subsequently, generating higher revenues for the cellular immunotherapy market.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Novartis AG
  • Gilead Sciences Inc. (Kite Pharma)
  • Apac Biotech
  • Dendreon Pharmaceuticals LLC
  • JW CreaGene Co. Ltd
  • Green Cross Corp (GC Pharma)
  • AstraZeneca
  • Bristol-Myers Squibb
  • Pfizer Inc.
  • Roche
  • Adicet Bio
  • ResTORbio
  • Celyad
Note: Product cover images may vary from those shown

Loading
LOADING...